Cargando…

Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment

There is evidence that naturally occurring antibodies directed against Aβ (nAbs-Aβ) have a role in Aβ-metabolism and Aβ-clearance. The presence of nAbs-Aβ leads to a reduction in amyloid fibrillation and thus a reduction in their toxicity. We investigated the effects of nAbs-Aβ in respect to oligome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mengel, D, Röskam, S, Neff, F, Balakrishnan, K, Deuster, O, Gold, M, Oertel, W H, Bacher, M, Bach, J-P, Dodel, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625912/ https://www.ncbi.nlm.nih.gov/pubmed/23462987 http://dx.doi.org/10.1038/tp.2012.151

Ejemplares similares

Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
por: Gold, Maike, et al.
Publicado: (2013)

Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein
por: Albus, Alexandra, et al.
Publicado: (2018)

Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia
por: Kronimus, Yannick, et al.
Publicado: (2016)

Prion Peptide Uptake in Microglial Cells – The Effect of Naturally Occurring Autoantibodies against Prion Protein
por: Roettger, Yvonne, et al.
Publicado: (2013)

Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
por: Heinzel, Sebastian, et al.
Publicado: (2014)

α(1)-antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicity
por: Gold, Maike, et al.
Publicado: (2014)

Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases
por: Albus, Alexandra, et al.
Publicado: (2019)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
por: Wentrup, Andreas, et al.
Publicado: (2009)

Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson’s Disease
por: Bach, Jan-Philipp, et al.
Publicado: (2015)

Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown
por: Schrader, Jörg, et al.
Publicado: (2009)

Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer’s disease
por: Liu, Yu-Hui, et al.
Publicado: (2021)

Venular amyloid accumulation in transgenic Fischer 344 Alzheimer’s disease rats
por: Bishay, J., et al.
Publicado: (2022)

Proliferation in the Alzheimer Hippocampus Is due to Microglia, Not Astroglia, and Occurs at Sites of Amyloid Deposition
por: Marlatt, Michael W., et al.
Publicado: (2014)

Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
por: Scheidt, Tom, et al.
Publicado: (2019)

Phenotypic analysis of a transgenic Drosophila model of Alzheimer’s amyloid-β toxicity
por: Sekiya, Michiko, et al.
Publicado: (2021)

Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
por: Malm, Tarja, et al.
Publicado: (2012)

Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies
por: Arevalo-Martin, Angel, et al.
Publicado: (2018)

Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
por: DiFrancesco, Jacopo C., et al.
Publicado: (2015)

Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients
por: Maftei, Madalina, et al.
Publicado: (2013)

Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
por: Zhang, She-Qing, et al.
Publicado: (2013)

Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease
por: Patel, Nikunj S, et al.
Publicado: (2005)

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010)

Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds
por: Stefani, Massimo, et al.
Publicado: (2013)

Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
por: Collins, Andrila E., et al.
Publicado: (2022)

T cell abnormalities in NZB mice occur independently of autoantibody production
Publicado: (1981)

Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s disease
por: Youm, Jung Won, et al.
Publicado: (2008)

Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid-β and Reverses Cognitive Deficits in Alzheimer Transgenic Mice
por: Lee, Sang-Hyun, et al.
Publicado: (2014)

Titration of biologically active amyloid–β seeds in a transgenic mouse model of Alzheimer's disease
por: Morales, Rodrigo, et al.
Publicado: (2015)

Trans ε viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model
por: Caillaud, Martial, et al.
Publicado: (2019)

Robust light–dark patterns and reduced amyloid load in an Alzheimer’s disease transgenic mouse model
por: Nagare, Rohan, et al.
Publicado: (2020)

In situ structural characterization of early amyloid aggregates in Alzheimer’s disease transgenic mice and Octodon degus
por: Benseny-Cases, Núria, et al.
Publicado: (2020)

Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease
por: Weber-Adrian, Danielle, et al.
Publicado: (2019)

Immunoregulation by Naturally Occurring and Disease-Associated Autoantibodies: Binding to Cytokines and Their Role in Regulation of T-Cell Responses
por: Nielsen, Claus H., et al.
Publicado: (2012)

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease
por: Klakotskaia, Diana, et al.
Publicado: (2018)

Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
por: Yang, Ting, et al.
Publicado: (2019)

Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice
por: Franko, Andras, et al.
Publicado: (2018)

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease
por: Kallhoff, Verena, et al.
Publicado: (2007)

Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer’s Transgenic Mice
por: Douglas Shytle, R, et al.
Publicado: (2012)

Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer’s disease transgenic mouse model
por: Lau, Jackie K. Y., et al.
Publicado: (2021)

Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer’s disease
por: Park, Sohui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5imckl7fbqg5sgjmcu2j8n4qlk